PATHOGENESIS OF TOXIC AND METABOLIC NEUROPATHIES

毒性和代谢性神经病的发病机制

基本信息

  • 批准号:
    3395444
  • 负责人:
  • 金额:
    $ 17.22万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1977
  • 资助国家:
    美国
  • 起止时间:
    1977-12-01 至 1992-03-31
  • 项目状态:
    已结题

项目摘要

The neurological consequences of diabetes exclusively affect the peripheral nervous system (PNS) and are linked to hypermetabolic activity in the sorbitol pathway and intrinsic microvascular changes which have long-term structural consequences. Hyperglycemia is the underlying defect and since nerves are insulin-independent, excess glucose enters the endoneurium being converted into osmotically active polyols. Transport mechanisms which convey hexoses across the blood-nerve barrier also carry sodium into the endoneurium resulting in increased osmotic activity associated with reduced nerve conduction velocity and reduced nerve fiber diameter in the early metabolic phase, during which neuropathy is most amenable to treatment with aldose reductase inhibitors and insulin. Our studies focus i) on the link between increased sodium and electrophysiologic disturbances, ii) fine structural localization of increased sodium in the axon and paranodal region and iii) mechanisms of glycogen accumulation in diabetic axons. In the latter stages of the disease microcirculatory changes become established and have an impact on the nerve fiber in which axonal degeneration and demyelination occur. Microangiopathy, resulting in narrowing of the capillaries, is implicated and the proposed research attaches particular significance to the transperineurial microcirculation which may play a key role in the pathogenesis of endoneurial ischemia. Both hyperglycemia and hypoxia are underlying mechanisms whose contributions to pathogenesis will be individually investigated using new techniques for measurement of nerve blood flow, endoneurial electrolyte analysis by x-ray microprobe, nerve oxygen tension and endoneurial fluid pressure. Biophysical techniques designed to investigate disturbances in the endoneurial microenvironment will be combined with classic morphologic and morphometric methods to determine the pathogenesis of the early changes in diabetic neuropathy knowledge of whose onset is crucial to initiate appropriate treatment before irreversible neuropathic changes supervene.
糖尿病的神经系统后果只影响

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

HENRY C. POWELL其他文献

HENRY C. POWELL的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('HENRY C. POWELL', 18)}}的其他基金

PAIRED HELICAL FILAMENTS AND PLAQUE AMYLOID PROTEINS
成对的螺旋丝和斑块淀粉样蛋白
  • 批准号:
    2050784
  • 财政年份:
    1991
  • 资助金额:
    $ 17.22万
  • 项目类别:
PATHOGENESIS OF VIRUS INDUCED BRAIN DISEASE
病毒引起的脑部疾病的发病机制
  • 批准号:
    3543556
  • 财政年份:
    1985
  • 资助金额:
    $ 17.22万
  • 项目类别:
CEREBROVASCULAR AMYLOID PROTEIN IN ALZHEIMER'S DISEASE
阿尔茨海默病中的脑血管淀粉样蛋白
  • 批准号:
    2049272
  • 财政年份:
    1985
  • 资助金额:
    $ 17.22万
  • 项目类别:
CEREBROVASCULAR AMYLOID PROTEIN IN ALZHEIMER'S DISEASE
阿尔茨海默病中的脑血管淀粉样蛋白
  • 批准号:
    2516898
  • 财政年份:
    1985
  • 资助金额:
    $ 17.22万
  • 项目类别:
CEREBROVASCULAR AMYLOID PROTEIN IN ALZHEIMER'S DISEASE
阿尔茨海默病中的脑血管淀粉样蛋白
  • 批准号:
    2049273
  • 财政年份:
    1985
  • 资助金额:
    $ 17.22万
  • 项目类别:
PATHOGENESIS OF VIRUS INDUCED BRAIN DISEASE
病毒引起的脑部疾病的发病机制
  • 批准号:
    3543557
  • 财政年份:
    1985
  • 资助金额:
    $ 17.22万
  • 项目类别:
PATHOGENESIS OF VIRUS INDUCED BRAIN DISEASE
病毒引起的脑部疾病的发病机制
  • 批准号:
    3543554
  • 财政年份:
    1985
  • 资助金额:
    $ 17.22万
  • 项目类别:
PATHOGENESIS OF VIRUS INDUCED BRAIN DISEASE
病毒引起的脑部疾病的发病机制
  • 批准号:
    3543558
  • 财政年份:
    1985
  • 资助金额:
    $ 17.22万
  • 项目类别:
PATHOGENESIS OF TOXIC AND METABOLIC NEUROPATHIES
毒性和代谢性神经病的发病机制
  • 批准号:
    2262606
  • 财政年份:
    1977
  • 资助金额:
    $ 17.22万
  • 项目类别:
PATHOGENESIS OF TOXIC AND METABOLIC NEUROPATHIES
毒性和代谢性神经病的发病机制
  • 批准号:
    3395447
  • 财政年份:
    1977
  • 资助金额:
    $ 17.22万
  • 项目类别:

相似海外基金

Energizing and Protecting Axons Through Metabolic Coupling to Schwann Cells
通过与雪旺细胞的代谢耦合来激活和保护轴突
  • 批准号:
    10647707
  • 财政年份:
    2023
  • 资助金额:
    $ 17.22万
  • 项目类别:
Energizing and Protecting Axons Through Metabolic Coupling to Schwann Cells
通过与雪旺细胞的代谢耦合来激活和保护轴突
  • 批准号:
    10768040
  • 财政年份:
    2023
  • 资助金额:
    $ 17.22万
  • 项目类别:
The role of change in expression levels of coagulation factors in Schwann cells in the neuropathic pain
雪旺细胞凝血因子表达水平变化在神经病理性疼痛中的作用
  • 批准号:
    23K06372
  • 财政年份:
    2023
  • 资助金额:
    $ 17.22万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The Role of Schwann Cells in the Progression of Melanoma
雪旺细胞在黑色素瘤进展中的作用
  • 批准号:
    10574973
  • 财政年份:
    2023
  • 资助金额:
    $ 17.22万
  • 项目类别:
YAP/TAZ in Schwann Cells as Potential Therapeutic Targets in CMT1A and HNPP.
雪旺细胞中的 YAP/TAZ 作为 CMT1A 和 HNPP 的潜在治疗靶点。
  • 批准号:
    10730544
  • 财政年份:
    2022
  • 资助金额:
    $ 17.22万
  • 项目类别:
Influence of peripheral schwann cells on neuropathic pain
外周雪旺细胞对神经病理性疼痛的影响
  • 批准号:
    22K09026
  • 财政年份:
    2022
  • 资助金额:
    $ 17.22万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Metabolic coupling between Schwann cells and axons is functionally distinct from myelination and is disrupted in obesity, prediabetes, and diabetes
雪旺细胞和轴突之间的代谢耦合在功能上不同于髓鞘形成,并且在肥胖、糖尿病前期和糖尿病中被破坏
  • 批准号:
    10689253
  • 财政年份:
    2022
  • 资助金额:
    $ 17.22万
  • 项目类别:
YAP/TAZ in Schwann Cells as potential therapeutic targets in CMT1A and HNPP.
雪旺细胞中的 YAP/TAZ 作为 CMT1A 和 HNPP 的潜在治疗靶点。
  • 批准号:
    10537511
  • 财政年份:
    2022
  • 资助金额:
    $ 17.22万
  • 项目类别:
Creating new therapies for lung cancer by targeting de-differentiated Schwann cells in the cancer microenvironment.
通过靶向癌症微环境中的去分化施万细胞,创造肺癌新疗法。
  • 批准号:
    22K09004
  • 财政年份:
    2022
  • 资助金额:
    $ 17.22万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Metabolic coupling between Schwann cells and axons is functionally distinct from myelination and is disrupted in obesity, prediabetes, and diabetes
雪旺细胞和轴突之间的代谢耦合在功能上不同于髓鞘形成,并且在肥胖、糖尿病前期和糖尿病中被破坏
  • 批准号:
    10518251
  • 财政年份:
    2022
  • 资助金额:
    $ 17.22万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了